|
|
Volumn 45, Issue 2-3, 2007, Pages 243-244
|
|
The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISOTRETINOIN;
RETINOIC ACID DERIVATIVE;
RETINOL;
ACNE CYSTICA;
ACUTE DISEASE;
BIRTH DEFECT;
CONCEPTION;
CONGENITAL MALFORMATION;
CONSERVATIVE TREATMENT;
COUNSELING;
DOSE RESPONSE;
DRUG INDICATION;
DRUG INDUSTRY;
ENVIRONMENTAL EXPOSURE;
FIRST TRIMESTER PREGNANCY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE PERSONNEL;
HEALTH PROGRAM;
HEALTH SERVICE;
HEART DISEASE;
HUMAN;
LETTER;
MEDICAL EDUCATION;
MEDICAL INFORMATION;
MENSTRUATION;
PRESCRIPTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK FACTOR;
SINGLE DRUG DOSE;
SPONTANEOUS ABORTION;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ABORTION, SPONTANEOUS;
DERMATOLOGIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
ISOTRETINOIN;
ITALY;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PRESCRIPTIONS, DRUG;
TRETINOIN;
|
|
EID: 34548310440
PISSN: 00917435
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ypmed.2007.04.010 Document Type: Letter |
|
Times cited : (6)
|
|
References (6)
|
